ABCG2 and cancer: It has also been reported that the activity of CUDC-907 in ABCG2-overexpressing cancer cells can be restored by inhibiting the function of the ATP-binding cassette drug transporter, ABCG2, which is one of the most common mechanisms for multidrug resistance in cancers [24].